Coherus Oncology, Inc. Debt Instrument, Interest Rate During Period
Coherus Oncology, Inc. (CHRS) reported Debt Instrument, Interest Rate During Period of 12.00% for the 3-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2026-03-09
- Coherus Oncology, Inc. debt instrument, interest rate during period for the quarter ending 2025-12-31 was 12.00%, a 4.76% decline year-over-year.
- Coherus Oncology, Inc. debt instrument, interest rate during period for the quarter ending 2024-12-31 was 12.60%.
| Period end | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month |
|---|---|---|---|
| 2025-12-31 | 12.00% 10-K · filed 2026-03-09 | ||
| 2024-12-31 | 12.60% 8-K · filed 2025-11-13 | ||
| 2024-09-30 | 13.30% 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | 13.30% 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |